Saturday, May 31, 2025

Latest

Li-Cycle: BMO Cuts Target After Negative Revenues Recorded In Q3

Li-Cycle (NYSE: LICY) recently reported its third-quarter financial results. The company reported revenues of -$2 million; this was due to an “unfavorable non-cash fair market value (FMV) pricing adjustment of $(7.3) million relating to prior-period black mass sales.” This made the company’s product sale segment come in at -$2.34 million, and recycling service revenues came in at $0.373 million.

Operating expenses for the quarter were $32.5 million, of this, share-based compensation was $4 million, and salaries and benefits came in at $9.5 million. Professional fees came in at $4.2 million. This brought the company’s net income to -$27.5 million, or earnings per share of -$0.16.

The company ended the quarter with $649 million of cash on hand and about $285 million in long-term convertible debt. The company said that it continues to evaluate multiple capital sources, such as debt and funding from potential strategic partners.

Li-Cycle currently has eight analysts covering the stock with an average 12-month price target of US$10.13, or an upside of 61%. Out of the eight analysts, two have strong buy ratings, four have buy ratings and the last two analysts have hold ratings. The street high price target sits at US$13 and represents an upside of 107%.

In BMO Capital Markets’ note on the results, they reiterated their outperform rating but cut their 12-month price target to $10 from $12, saying that they acknowledge that the stock could trade sideways until the Rochester Hub-plant completion which is expected to be around the end of 2023, and expects there to be more growing pains ahead.

Even with that, BMO writes, “Li-Cycle is still a well-capitalized first-mover as a Western battery recycler; is well positioned to benefit from various government led OpEx/funding assistance programs to be deployed over the near-term; and is backstopped by further moat support given its Tier-1 partners.”

As a result of the earnings, BMO has reset its expectations on earnings going forward. They now expect EBITDA to be $225 million in 2025 with an EBITDA margin of 44%. Additionally, with the Rochester Hub expected to be done by late 2023, they expect a company de-risking to happen during 2024.

As a result of this, BMO now expects that the Hub-2 start-up will happen roughly 2 to 3 years after the Richester Hub is completed. Additionally, they expect Li-Cycle to get a 10% OpEx subsidy to their US recycling plants. Subsidies will primarily be for processing costs and not battery metal feedstock.

Below you can see BMO Capital Markets’ updated estimates on Li-Cycle.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

Skylight Health: Echelon, Beacon Securities Initiate Coverage On Firm

Last week Echelon Wealth Partners and Beacon Securities both initiated coverage on Skylight Health Group...

Sunday, December 13, 2020, 01:45:00 PM

Peloton: BMO Remains As The Bear Following Q4 Results

At the tail end of August, Peloton Interactive (NASDAQ: PTON) reported its fiscal fourth quarter...

Saturday, September 4, 2021, 01:10:00 PM

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Canaccord Reiterates Speculative Buy Rating, $3.70 Price Target For Battle North Gold

On Thursday, Battle North Gold (TSXV: BNAU) reported additional high-grade assay results from their confirmatory...

Sunday, September 27, 2020, 01:35:00 PM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM